MCTP1-AS1

Across TCGA pan-cancer cohorts, MCTP1-AS1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MCTP1-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MCTP1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MCTP1-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

BLCA, LUSC, and THCA are the cancer types where MCTP1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.182	0.525	<.001	144	view →
LUSC	OS	Tertile	II,III,IV	0.272	0.749	<.001	90	view →
THCA	OS	Tertile	III,IV	0.548	0.963	<.001	66	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →
SARC	OS	Tertile	All	0.214	0.601	.017	6	view →
LUAD	DFS	Tertile	All	0.632	0.335	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MCTP1-AS1–BLCA (DFS)

Open the BLCA breakdown →